International Business News - Pharmaceutical http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Shares of Teva Pharmaceutical Industries Ltd. fell Friday as Momenta Pharmaceuticals Inc. turned the tables on the generic drug developer by challenging the patent on its lucrative multiple sclerosis drug. http://www.ibtimes.com/articles/20080711/teva-pharma-shares-fall-on-drug-patent-challenge.htm Fri, 11 Jul 2008 16:07:41 EDT Shares of Teva Pharmaceutical Industries Ltd. inched up in premarket trading Tuesday, and a Goldman Sachs analyst recommended the stock despite disappointing trial results for Teva's multiple sclerosis drug Copaxone. http://www.ibtimes.com/articles/20080708/ahead-of-the-bell-teva-shares-edge-up.htm Tue, 08 Jul 2008 07:34:16 EDT Israeli drug maker Teva Pharmaceutical Industries Ltd. said Monday results from a late-stage study showed a higher dose of its multiple sclerosis drug Copaxone was not more effective than a lower, standard dose. http://www.ibtimes.com/articles/20080707/higher-dose-of-teva-ms-drug-not-more-effective.htm Mon, 07 Jul 2008 07:42:53 EDT Teva Pharmaceutical Industries Ltd. said Tuesday a U.S. court ruled against it in an ongoing patent challenge over the anti-psychotic drug Seroquel and the Israel-based drug developer plans to appeal the decision. http://www.ibtimes.com/articles/20080701/teva-loses-patent-dispute-plans-appeal.htm Tue, 01 Jul 2008 17:31:17 EDT Par Pharmaceutical Cos. shares rose Monday after the company said the Food and Drug Administration approved its generic version of Solvay Pharmaceutical's chemotherapy side effect treatment. http://www.ibtimes.com/articles/20080630/par-pharmaceutical-shares-rise-on-generic-drug-ok.htm Mon, 30 Jun 2008 20:10:46 EDT Among the stock activity stories for Monday, June 16, from AP Financial News: NEW YORK (AP)--Shares of Teva Pharmaceutical Industries Ltd. rose Monday after the company posted data showing its Parkinson's drug Azilect can slow progression of the disease, prompting a Merrill Lynch analyst to raise his rating on the stock to "Buy" from "Neutral." http://www.ibtimes.com/articles/20080616/movers-roundup-teva-kulicke-soffa.htm Mon, 16 Jun 2008 14:37:28 EDT KV Pharmaceutical Co. said Monday its fiscal 2008 fourth-quarter profit fell 47 percent on charges related to the acquisition of a drug, but excluding those charges, beat analyst expectations. http://www.ibtimes.com/articles/20080616/kv-4q-profit-falls-on-charges-but-tops-estimates.htm Mon, 16 Jun 2008 09:39:20 EDT Israeli pharmaceutical company Teva Pharmaceutical Industries Ltd. said Thursday the U.S. Food and Drug Administration tentatively approved the company's application to market a generic version of hypertension drug Diovan. http://www.ibtimes.com/articles/20080612/teva-wins-tentative-fda-approval-for-drug.htm Thu, 12 Jun 2008 15:16:46 EDT KV Pharmaceutical Co. said Tuesday a subsidiary's patent on the prenatal vitamin product PrimaCare One is being challenged by generic drug developer Lannett Co. http://www.ibtimes.com/articles/20080610/kv-unit-sued-by-lannett-in-patent-challenge.htm Tue, 10 Jun 2008 17:55:10 EDT Medicis Pharmaceutical Corp. raised its full-year profit guidance Thursday after its first-quarter results topped expectations. The company expects 2008 profit between $1.49 and $1.58 per share on revenue between $529 million and $538 million. In February, the company set full-year profit guidance between $1.43 and $1.56 per share on revenue between $528 million and $540 million. Analysts on average expect a profit of $1.51 per share on revenue $534.4 million. http://www.ibtimes.com/articles/20080508/medicis-pharmaceutical-raises-full-year-profit-outlook.htm Thu, 08 May 2008 16:52:06 EDT Par Pharmaceutical Cos. said Wednesday it will pay Spectrum Pharmaceuticals Inc. $20 million in cash for its stake in a generic migraine injection. The payment will give Par 95 percent of the profits from the generic version of GlaxoSmithKline's Imitrex injection, up from its prior 38 percent stake. http://www.ibtimes.com/articles/20080507/par-to-pay-spectrum-20m-for-its-stake-in-generic-injection.htm Wed, 07 May 2008 09:56:17 EDT Chinese generic drug developer Simcere Pharmaceutical Group on Tuesday reiterated a full-year outlook above Wall Street's estimates, based on current operating and market conditions. http://www.ibtimes.com/articles/20080506/simcere-pharmaceutical-maintains-full-year-outlook.htm Tue, 06 May 2008 10:06:39 EDT Teva Pharmaceutical Industries Ltd., the world's largest generic drugmaker, said Tuesday its first-quarter profit fell on a hefty charge related to its purchase of CoGenesys, but adjusted earnings topped Wall Street expectations. http://www.ibtimes.com/articles/20080506/teva-pharma-1q-profit-falls-on-charge-but-tops-estimate.htm Tue, 06 May 2008 07:26:32 EDT The vice president of human resources for biotechnology company BioMarin Pharmaceutical Inc. exercised options for 2,990 shares of common stock under a prearranged trading plan, according to a Securities and Exchange Commission filing Tuesday. http://www.ibtimes.com/articles/20080423/biomarin-pharma-vp-of-human-resources-wood-exercises-options.htm Wed, 23 Apr 2008 13:39:17 EDT Major job cuts by pharmaceutical companies since January 2007, and when they were announced: Schering-Plough Corp., 5,500 jobs, 10 percent of staff (April 2) Wyeth, 5,000 jobs, or 10 percent, Jan. ... http://www.ibtimes.com/articles/20080404/a-look-at-drug-industry-layoffs.htm Fri, 04 Apr 2008 18:05:08 EDT Drug makers beset by growing generic competition, few new blockbusters, drug safety concerns and pressure from insurers and government health programs to discount prices are cutting tens of thousands... http://www.ibtimes.com/articles/20080404/more-layoffs-cuts-at-drug-makers.htm Fri, 04 Apr 2008 17:23:56 EDT The Pharmaceutical Research and Manufacturers of America paid Tongour Simpson Holsclaw & Cooney $240,000 in 2007 to lobby the government. The payment was part of an extensive effort last year by the industry's main trade group, which spent $22 million lobbying overall. The firm lobbied Congress on legislation dealing with patent reform, intellectual property issues and drug imports. http://www.ibtimes.com/articles/20080303/pharmaceutical-group-lobbied-on-patents.htm Mon, 03 Mar 2008 20:36:51 EST Shares of drug developer Par Pharmaceutical Co. jumped Monday after the company topped Wall Street profit expectations, even though analysts were skeptical on the strength of its business. http://www.ibtimes.com/articles/20080303/par-shares-rise-on-4q-financial-results.htm Mon, 03 Mar 2008 18:09:38 EST West Pharmaceutical Services Inc. said its board declared a regular quarterly dividend of 14 cents. The medical device maker said the dividend is payable May 7 to shareholders of record April 23. http://www.ibtimes.com/articles/20080228/west-pharmaceutical-sets-dividend.htm Thu, 28 Feb 2008 15:57:05 EST Medicis Pharmaceutical Corp. said Wednesday its fourth-quarter profit jumped 54 percent on higher sales of the company's acne treatment products. The company earned $27.5 million, or 41 cents per share, compared with profit of $17.9 million, or 27 cents per share, during the same period a year prior. Revenue rose 42 percent to $140.3 million from $99.1 million. http://www.ibtimes.com/articles/20080227/medicis-4q-profit-rises-on-acne-products.htm Wed, 27 Feb 2008 18:24:53 EST